Cargando…
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer
The present study investigated the interaction between c-erbB2 overexpression and the response to first-line endocrine therapy in patients with advanced breast cancer. The primary tumours of 241 patients who were treated at first relapse with endocrine therapy were assessed for overexpression of c-e...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1999
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362250/ https://www.ncbi.nlm.nih.gov/pubmed/10098763 http://dx.doi.org/10.1038/sj.bjc.6690196 |